The efficacy and safety of loratadine pseudoephedrine sulfate was compared with carbinoxamine maleate phenylephrine HCI in a single blind study in the treatment of 77 patients with allergic rhinitis. The gradation were moderate and severe (the minimal score was 6 for nasal symptoms). Treatment were administered orally twice daily for 14 days and were evaluated at baseline and on days 4, 8 and 1…